Cyclo Therapeutics Probability of Future Stock Price Finishing Over 0.72
| CYTHDelisted Stock | USD 0.72 0.06 9.09% |
Cyclo |
Cyclo Therapeutics Target Price Odds to finish over 0.72
The tendency of Cyclo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.72 | 90 days | 0.72 | about 59.87 |
Based on a normal probability distribution, the odds of Cyclo Therapeutics to move above the current price in 90 days from now is about 59.87 (This Cyclo Therapeutics probability density function shows the probability of Cyclo Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Cyclo Therapeutics has a beta of 0.78 suggesting as returns on the market go up, Cyclo Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cyclo Therapeutics will be expected to be much smaller as well. Additionally Cyclo Therapeutics has an alpha of 0.3652, implying that it can generate a 0.37 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Cyclo Therapeutics Price Density |
| Price |
Predictive Modules for Cyclo Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cyclo Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyclo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cyclo Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cyclo Therapeutics is not an exception. The market had few large corrections towards the Cyclo Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cyclo Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cyclo Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.37 | |
β | Beta against Dow Jones | 0.78 | |
σ | Overall volatility | 0.12 | |
Ir | Information ratio | 0.04 |
Cyclo Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cyclo Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cyclo Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cyclo Therapeutics is not yet fully synchronised with the market data | |
| Cyclo Therapeutics has some characteristics of a very speculative penny stock | |
| Cyclo Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.08 M. Net Loss for the year was (20.06 M) with profit before overhead, payroll, taxes, and interest of 794.48 K. | |
| Cyclo Therapeutics currently holds about 4.29 M in cash with (16.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51. | |
| Roughly 48.0% of the company shares are held by company insiders |
Cyclo Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cyclo Stock often depends not only on the future outlook of the current and potential Cyclo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cyclo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.3 M | |
| Cash And Short Term Investments | 9.2 M | |
| Shares Float | 11.5 M |
Cyclo Therapeutics Technical Analysis
Cyclo Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Cyclo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cyclo Therapeutics. In general, you should focus on analyzing Cyclo Stock price patterns and their correlations with different microeconomic environments and drivers.
Cyclo Therapeutics Predictive Forecast Models
Cyclo Therapeutics' time-series forecasting models is one of many Cyclo Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cyclo Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Cyclo Therapeutics
Checking the ongoing alerts about Cyclo Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cyclo Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Cyclo Therapeutics is not yet fully synchronised with the market data | |
| Cyclo Therapeutics has some characteristics of a very speculative penny stock | |
| Cyclo Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.08 M. Net Loss for the year was (20.06 M) with profit before overhead, payroll, taxes, and interest of 794.48 K. | |
| Cyclo Therapeutics currently holds about 4.29 M in cash with (16.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51. | |
| Roughly 48.0% of the company shares are held by company insiders |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Cyclo Stock
If you are still planning to invest in Cyclo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cyclo Therapeutics' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |